Risk Of Developing Liver Cancer After HCV Treatment

Friday, October 28, 2016

Liver fibrosis: Which mechanisms matter?

Of Interest - Is There A Natural Way To Improve Liver Fibrosis?

The latest issue of Clinical Liver Disease is available on Wiley Online Library

Clinical Liver Disease is an official digital educational learning resource from the American Association for the Study of Liver Diseases.

Visitors are able to view videos, access full text articles, and download files in either HTML or PDF formats.

Reviews
Implications of Translational Research
Guest Edited by Frank Tacke, MD

New pharmacological approaches to a functional cure of hepatitis B (pages 83–88)
Wai-Kay Seto and Man-Fung Yuen
Version of Record online: 27 OCT 2016 | DOI: 10.1002/cld.577


The transition from inflammation to cancer in the liver (pages 89–93)
Augusto Villanueva and Tom Luedde
Version of Record online: 27 OCT 2016 | DOI: 10.1002/cld.578


Liver fibrosis: Which mechanisms matter? (pages 94–99)
Ralf Weiskirchen and Frank Tacke
Version of Record online: 27 OCT 2016 | DOI: 10.1002/cld.581


Hepatocellular Carcinoma and Nonalcoholic Steatohepatitis (NASH)
Guest Edited by Gregory Gores, MD



Natural history of nonalcoholic steatohepatitis–associated hepatocellular carcinoma (pages 105–107)
Stefano Bellentani, Gianluca Svegliati Baroni, Fabio Piscaglia and Claudio Tiribelli
Version of Record online: 27 OCT 2016 | DOI: 10.1002/cld.582


In My Opinion
Guest Edited by Jay Talwalkar, MD
New organ allocation policy in liver transplantation in the United States (pages 108–112)
David A. Goldberg, Richard Gilroy and Michael Charlton
Version of Record online: 27 OCT 2016 | DOI: 10.1002/cld.580




The latest issue of Clinical Liver Disease is available on Wiley Online Library

No comments:

Post a Comment